Cargando…
Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC)
BACKGROUND: Takayasu arteritis (TAK) is an immune-induced granulomatous vasculitis that occurs primarily in young Asian women. Our previous cohort studies have indicated that leflunomide (LEF), which can lead to rapid induction and might be a promising alternative treatment for TAK. OBJECTIVES: To c...
Autores principales: | Sun, Ying, Wu, Bingjie, Zhang, Wei, Ma, Lili, Kong, Xiufang, Chen, Huiyong, Jiang, Lindi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989417/ https://www.ncbi.nlm.nih.gov/pubmed/36895331 http://dx.doi.org/10.1177/20406223231158567 |
Ejemplares similares
-
Effectiveness and safety of methotrexate versus
leflunomide in 12-month treatment for Takayasu arteritis
por: Wu, Chunling, et al.
Publicado: (2020) -
Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu’s arteritis: an observational study
por: Dai, Xiaomin, et al.
Publicado: (2020) -
Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study
por: Ying, Sun, et al.
Publicado: (2020) -
Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis
por: Kong, Xiufang, et al.
Publicado: (2021) -
Takayasu Arteritis
por: Russo, Ricardo A. G., et al.
Publicado: (2018)